Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial of Neoadjuvant Leuprorelin, Darolutamide or Both Prior to Radical Prostatectomy for Intermediate or High-risk Prostate Cancer

NCT06627530 is registered in ClinicalTrials.gov with Brazilian Clinical Research Institute as lead sponsor.

NCT NCT06627530
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06627530 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial of Neoadjuvant Leuprorelin, Darolutamide or Both Prior to Radical Prostatectomy for Intermediate or High-risk Prostate Cancer
Lead sponsor
Brazilian Clinical Research Institute
Phase
Phase 4
Overall status
Active, not recruiting
Start date
February 17, 2025
Completion date
September 30, 2026
Enrollment
144 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer